Question 53

Pantoprazole is an appropriate therapeutic substitution for omeprazole.

Both omeprazole and pantoprazole belong to the class of medications known as proton pump inhibitors (PPIs), which are used to decrease stomach acid production and treat conditions such as gastroesophageal reflux disease (GERD) and peptic ulcers.

A) Mebendazole

Mebendazole is an anthelmintic medication used to treat parasitic worm infections. It does not belong to the category of proton pump inhibitors and therefore cannot serve as a therapeutic substitution for omeprazole.

B) Ketoconazole

Ketoconazole is an antifungal medication that also has some effects on stomach acid but is not a proton pump inhibitor. It is not indicated for the same therapeutic uses as omeprazole, making it an inappropriate substitution.

C) Fluconazole

Fluconazole is another antifungal medication and does not function as a proton pump inhibitor. It is used for treating fungal infections and lacks the acid-reducing properties of omeprazole, thus it cannot be considered a suitable substitute.

D) Pantoprazole

Pantoprazole is indeed a proton pump inhibitor, similar to omeprazole, and is used to manage conditions related to excessive stomach acid. It can effectively replace omeprazole in a therapeutic setting due to its similar mechanism of action and efficacy.

Conclusion

Pantoprazole is definitively the correct choice as it directly matches the therapeutic class and function of omeprazole. The other options fail to provide the necessary acid-reducing effect required for the conditions treated by omeprazole, reinforcing pantoprazole's role as an appropriate substitution.